Left Ventricular Remodeling After Catheter Ablation of Atrial Fibrillation: Changes of Myocardial Extracellular Volume Fraction by Cardiac MRI
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study is to demonstrate the association between recurrent atrial fibrillation (AF) and left ventricular (LV) adverse remodeling after catheter ablation and to evaluate the change of myocardial extracellular volume fraction (ECV) by catheter ablation outcomes. Materials and Methods: We retrospectively recruited 60 patients (44 men and 16 women) with a median age of 57 years (range, 32–78 years) who underwent cardiac MRI before and at 6–12 months after catheter ablation of AF. Cardiac MRI quantified myocardial ECV (%) in the left ventricle. Depending on myocardial ECV after catheter ablation, patients were divided into two groups: 1) LV adverse remodeling with ECV ≥ 28%; and 2) no adverse LV remodeling with ECV < 28%. Multivariable analysis was performed to assess the association between recurrent AF and LV remodeling. Results: Of 60 patients, 21 (35%) were in the LV adverse remodeling group (mean ECV ± standard deviation [SD]: 29.8% ± 1.4%) and 39 (65%) were in the no adverse LV remodeling group (mean ECV ± SD: 24.7% ± 1.5%). The incidence of recurrent AF was significantly greater in the LV adverse remodeling group than in the no adverse LV remodeling group (81% vs. 13%, p < 0.001). In patients with recurrent AF, mean myocardial ECV significantly increased from 27.7% ± 2.3% to 29.2% ± 2.3% (p = 0.004) after catheter ablation. In a multivariable analysis after adjusting sex, age, and myocardial ECV before catheter ablation, recurrent AF was independently associated with LV adverse remodeling after catheter ablation (odds ratio: 28.9, 95% confidence interval: 6.8–121.7, p < 0.001). Conclusion: When monitoring with cardiac MRI, sustained AF was significantly associated with LV adverse remodeling through an increase in myocardial ECV after catheter ablation of AF.
Abstract
Purpose: The aim of this study is to demonstrate the association between recurrent atrial fibrillation (AF) and left ventricular (LV) adverse remodeling after catheter ablation and to evaluate the change of myocardial extracellular volume fraction (ECV) by catheter ablation outcomes. Materials and Methods: We retrospectively recruited 60 patients (44 men and 16 women) with a median age of 57 years (range, 32–78 years) who underwent cardiac MRI before and at 6–12 months after catheter ablation of AF. Cardiac MRI quantified myocardial ECV (%) in the left ventricle. Depending on myocardial ECV after catheter ablation, patients were divided into two groups: 1) LV adverse remodeling with ECV ≥ 28%; and 2) no adverse LV remodeling with ECV < 28%. Multivariable analysis was performed to assess the association between recurrent AF and LV remodeling. Results: Of 60 patients, 21 (35%) were in the LV adverse remodeling group (mean ECV ± standard deviation [SD]: 29.8% ± 1.4%) and 39 (65%) were in the no adverse LV remodeling group (mean ECV ± SD: 24.7% ± 1.5%). The incidence of recurrent AF was significantly greater in the LV adverse remodeling group than in the no adverse LV remodeling group (81% vs. 13%, p < 0.001). In patients with recurrent AF, mean myocardial ECV significantly increased from 27.7% ± 2.3% to 29.2% ± 2.3% (p = 0.004) after catheter ablation. In a multivariable analysis after adjusting sex, age, and myocardial ECV before catheter ablation, recurrent AF was independently associated with LV adverse remodeling after catheter ablation (odds ratio: 28.9, 95% confidence interval: 6.8–121.7, p < 0.001). Conclusion: When monitoring with cardiac MRI, sustained AF was significantly associated with LV adverse remodeling through an increase in myocardial ECV after catheter ablation of AF.
참고문헌 (21)
- Calkins H, "2017 HRS", EHRA, APHRS, pp.SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation : executive summary, Europace[DOI]
- January CT, "2019 AHA", ACC, ACC, pp.HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons[DOI]
- Gentlesk PJ, "Reversal of left ventricular dysfunction following ablation of atrial fibrillation", J Cardiovasc Electrophysiol, 18, pp.9~14 (2007)
- Kirchhof P, "2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Eur Heart J, 37, pp.2893~2962 (2016)
- Cohn JN, "Cardiac remodeling—concepts and clinical implications : a consensus paper from an International Forum on Cardiac Remodeling", J Am Coll Cardiol, 35, pp.569~582 (2000)
- Haaf P, "Cardiac T1 mapping and extracellular volume(ECV)in clinical practice : a comprehensive review", J Cardiovasc Magn Reson, 18, pp.89~ (2016)
- Kellman P, "Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method", J Cardiovasc Magn Reson, 14, pp.63~ (2012)
- Schelbert EB, "Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage", J Am Heart Assoc, 4, pp.e002613~ (2015)
- Zhuang B, "Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease : a systematic review and meta-analysis", Heart Fail Rev, 23, pp.723~731 (2018)
- Li S, "Left ventricular fibrosis by extracellular volume fraction and the risk of atrial fibrillation recurrence after catheter ablation", Cardiovasc Diagn Ther, 9, pp.578~585 (2019)
- Neilan TG, "Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation", JACC Cardiovasc Imaging, 7, pp.1~11 (2014)
- Bulluck H, "Automated extracellular volume fraction mapping provides insights into the pathophysiology of left ventricular remodeling post-reperfused ST-elevation myocardial infarction", J Am Heart Assoc, 5, pp.e003555~ (2016)
- Ando K, "Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy : analysis by T2* BOLD and T1 mapping MRI", Eur Radiol, 30, pp.4327~4336 (2020)
- Shrout PE, "Intraclass correlations : uses in assessing rater reliability", Psychol Bull, 86, pp.420~428 (1979)
- Robinson AA, "Myocardial T1 and ECV measurement:underlying concepts and technical considerations", JACC Cardiovasc Imaging, 12(11 Pt 2), pp.2332~2344 (2019)
- Roy C, "Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR", J Cardiovasc Magn Reson, 19, pp.72~ (2017)
- Yeseul Jo, "Guideline for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging—Part 1: Standardized Protocol", Korean Journal of Radiology, 20(9), pp.1313~1333 (2019), 대한영상의학회[DOI]
- Karamitsos TD, "Myocardial tissue characterization and fibrosis by imaging", JACC Cardiovasc Imaging, 13, pp.1221~1234 (2020)
- Ugander M, "Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology", Eur Heart J, 33, pp.1268~1278 (2012)
- Hwang SH, "Evaluation of extracellular volume fraction thresholds corresponding to myocardial lategadolinium enhancement using cardiac magnetic resonance", Int J Cardiovasc Imaging, 30(Suppl 2), pp.137~144 (2014)
- Wijesurendra RS, "Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation", Circulation, 134, pp.1068~1081 (2016)